Chronic lymphocytic leukaemia: A new treatment era is born
Chronic lymphocytic leukaemia: A new treatment era is born
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3
Final stage II results of the CLL11 trial
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531
Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease
Multidisciplinary in cancer care in India
Goals of 1st Indian Cancer Congress
Plurality of cancer
Recent advances in surgery, radiotherapy and targeted treatment for cervical cancer
Cancer cells and the immune system: a natural story?
Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction
Immuno-Oncology: a concept or already a reality?